NCS1

gene
On this page

Also known as NCS-1

Summary

NCS1 (neuronal calcium sensor 1, HGNC:3953) is a protein-coding gene on chromosome 9q34.11, encoding Neuronal calcium sensor 1 (P62166). Neuronal calcium sensor, regulator of G protein-coupled receptor phosphorylation in a calcium dependent manner.

This gene is a member of the neuronal calcium sensor gene family, which encode calcium-binding proteins expressed predominantly in neurons. The protein encoded by this gene regulates G protein-coupled receptor phosphorylation in a calcium-dependent manner and can substitute for calmodulin. The protein is associated with secretory granules and modulates synaptic transmission and synaptic plasticity. Multiple transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 23413 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 23 total
  • Druggable target: yes
  • MANE Select transcript: NM_014286

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:3953
Approved symbolNCS1
Nameneuronal calcium sensor 1
Location9q34.11
Locus typegene with protein product
StatusApproved
AliasesNCS-1
Ensembl geneENSG00000107130
Ensembl biotypeprotein_coding
OMIM603315
Entrez23413

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 7 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000372398, ENST00000493042, ENST00000630865, ENST00000937011, ENST00000937012, ENST00000946320, ENST00000946321, ENST00000946322

RefSeq mRNA: 2 — MANE Select: NM_014286 NM_001128826, NM_014286

CCDS: CCDS6932, CCDS78448

Canonical transcript exons

ENST00000372398 — 8 exons

ExonStartEnd
ENSE00000927338130217832130217970
ENSE00000927339130219725130219803
ENSE00000927340130222650130222738
ENSE00000927341130223082130223159
ENSE00001052772130226389130226504
ENSE00001457687130232990130237303
ENSE00001457688130172404130172727
ENSE00003506681130200958130200982

Expression profiles

Bgee: expression breadth ubiquitous, 226 present calls, max score 98.84.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 39.1790 / max 506.9513, expressed in 1704 samples.

FANTOM5 promoters (12 alternative TSS)

Promoter IDTPM avgSamples expressed
9899231.62661700
989933.70041311
989951.0262639
989940.6209336
989960.6159387
989970.5240293
990050.3693150
990030.2801122
990060.170270
989980.123457

Top tissues by expression

279 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right frontal lobeUBERON:000281098.84gold quality
anterior cingulate cortexUBERON:000983598.38gold quality
amygdalaUBERON:000187698.28gold quality
nucleus accumbensUBERON:000188298.28gold quality
cingulate cortexUBERON:000302798.26gold quality
dorsolateral prefrontal cortexUBERON:000983497.79gold quality
postcentral gyrusUBERON:000258197.69gold quality
prefrontal cortexUBERON:000045197.13gold quality
Brodmann (1909) area 9UBERON:001354097.13gold quality
caudate nucleusUBERON:000187397.12gold quality
Ammon’s hornUBERON:000195497.05gold quality
parietal lobeUBERON:000187297.02gold quality
frontal cortexUBERON:000187096.81gold quality
neocortexUBERON:000195096.72gold quality
temporal lobeUBERON:000187196.54gold quality
cortical plateUBERON:000534396.44gold quality
lateral nuclear group of thalamusUBERON:000273696.36gold quality
cerebral cortexUBERON:000095696.20gold quality
telencephalonUBERON:000189396.20gold quality
right hemisphere of cerebellumUBERON:001489095.91gold quality
superior frontal gyrusUBERON:000266195.54gold quality
putamenUBERON:000187495.53gold quality
mucosa of stomachUBERON:000119995.50gold quality
muscle layer of sigmoid colonUBERON:003580595.48gold quality
cerebellar hemisphereUBERON:000224595.33gold quality
cerebellar cortexUBERON:000212995.28gold quality
popliteal arteryUBERON:000225095.26gold quality
tibial arteryUBERON:000761095.25gold quality
lower esophagus muscularis layerUBERON:003583395.09gold quality
lower esophagusUBERON:001347395.05gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-MTAB-7303no962.15
E-GEOD-109979no66.76
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

159 targeting NCS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-3924100.0072.092394
HSA-MIR-4673100.0066.641490
HSA-MIR-12118100.0065.881270
HSA-MIR-4476100.0068.182030
HSA-MIR-4692100.0067.322066
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-200B-3P100.0073.312693
HSA-MIR-200C-3P100.0073.352685
HSA-MIR-429100.0073.442698
HSA-MIR-6798-5P100.0065.77699
HSA-MIR-451499.9967.101870
HSA-MIR-607799.9968.042299
HSA-MIR-806899.9873.852376
HSA-MIR-4645-5P99.9865.811284
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-4650-5P99.9864.69999
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-314899.9775.066478
HSA-MIR-4725-3P99.9669.532520
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-6780B-5P99.9669.602562
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-6835-3P99.9370.492904
HSA-MIR-497-5P99.9271.832674

Literature-anchored findings (GeneRIF, showing 35)

  • up-regulated in the prefrontal cortex of schizophrenic and bipolar patients (PMID:12496348)
  • Analysis with chimeric proteins between KChIP2 and NCS-1 reveals that the three regions of KChIP2 are necessary and sufficient for its effective binding to Kv4.3 protein (PMID:12928444)
  • may serve as regulator of certain isoforms of phosphatidylinositol 4-kinase (PMID:14512421)
  • key role for residues within the motif EELTRK in NCS-1 in keeping the myristoyl group exposed and allowing the protein to be constitutively membrane-associated. (PMID:14726528)
  • NCS-1 is shown to be mainly associated with azurophilic granules in human neutrophils and promyelocitic cells and, therefore could play an instrumental role in the calcium-dependent secretion of azurophilic granules (PMID:14760944)
  • These results demonstrate a novel role for NCS-1 and PI4Kbeta in regulating ERK1/2 signaling and inflammatory reactions in mast cells. (PMID:16837555)
  • occurrence of an unusual TG 3’ splice site in intron 2 (PMID:17672918)
  • NCS-1 expression was diminished in CD4+T lymphocytes, CD19+ B lymphocytes and CD14+ monocytes of bipolar disorder patients and also decreased in CD4+ T lymphocytes and CD56+ natural killer cells of schizophrenia patients (PMID:19091302)
  • Impairment of the normal cycling of NCS-1 by the R102Q mutation could have subtle effects on neuronal signalling and physiology in the developing and adult brain. (PMID:20479890)
  • NCS-1 is a novel regulator of cardiac calcium signaling, specifically in immature and hypertrophic hearts. (PMID:21737792)
  • [review] Receptor interaction properties in schizophrenia are dependent upon NCS-1, a protein found to regulate the phosphorylation, trafficking, and signaling profile of the D2 dopamine receptor (D2R) in neurons. (PMID:21777187)
  • it is possible to protect cells from paclitaxel-induced degradation of NCS-1 by inhibiting calpain activity (PMID:21808066)
  • analysis of the interaction between the D2 dopamine receptor and neuronal calcium sensor-1 (PMID:21875085)
  • the C-terminal tail is important for regulating the conformational stability of NCS1 in Ca(2+)-activated state (PMID:22227393)
  • data suggest that genetic variants in the NCS-1 gene contribute to susceptibility of Cocaine Abuse in individuals of African descent. (PMID:22999924)
  • NCS1 has evolved a remarkable complex interdomain cooperativity and a fundamentally different folding mechanism compared to structurally related proteins. (PMID:24012477)
  • The functional link in substantia nigra dopamine neurons between Cav1.3- L-type-Ca2+ channels and D2-autoreceptor activity is an adaptive signalling network controlled by NCS-1. (PMID:24934288)
  • single-molecule optical tweezers were used to monitor misfolding reactions of the human neuronal calcium sensor-1. (PMID:25157171)
  • results reveal the important role of salt bridges on the structural properties of NCS-1 protein and that R102Q mutation disables the dynamic relocation of C-terminus, which may block the binding of NCS-1 protein to its receptors (PMID:25343687)
  • A strong liason was characterized between myristoylation and cryptic EF-1 in NCS-1. (PMID:25565019)
  • Study determined the salient features of the folding free-energy landscapes of the Mg2+-bound and apo states of NCS-1 (PMID:26153708)
  • structural and dynamical response of NCS-1 protein to elevated temperature may be one of its intrinsic functional properties (PMID:27007011)
  • Lithium normalizes gamma band oscillations mediated by P/Q-type calcium channels modulated by NCS-1. (PMID:27033453)
  • Results show that although NCS-1 Var2mRNA can be detected, protein expression was not detectable. When overexpressed in cell lines NCS-1 Var2 appears to be folded properly, yet it has a lower calcium affinity. Because most NCS-1 binding to its protein partners requires calcium binding, it is unlikely that NCS-1 Var2 would play a major regulatory role in cells. (PMID:27575489)
  • NCS-1, a calcium-binding protein, is associated with clinicopathologic features of aggressiveness in breast cancer cells and worse outcome in two breast cancer patient cohorts (PMID:28275088)
  • High NCS1 expression is associated with Hepatocellular Carcinoma. (PMID:29789326)
  • NCS1 regulates endoplasmic reticulum-mitochondria cross-talk, which is impaired in Wolfram syndrome (PMID:30352948)
  • NCS-1 expression is higher in basal breast cancers and regulates calcium influx and cytotoxic responses to doxorubicin. (PMID:31647602)
  • NCS-1 levels were reduced in a human iPSC-model of familial Parkinson’s. (PMID:31704946)
  • Membrane Binding of Neuronal Calcium Sensor-1: Highly Specific Interaction with Phosphatidylinositol-3-Phosphate. (PMID:31973069)
  • Neuronal Calcium Sensor 1 is up-regulated in response to stress to promote cell survival and motility in cancer cells. (PMID:32239615)
  • Disorder in a two-domain neuronal Ca(2+)-binding protein regulates domain stability and dynamics using ligand mimicry. (PMID:32936312)
  • Disulfide Dimerization of Neuronal Calcium Sensor-1: Implications for Zinc and Redox Signaling. (PMID:34830487)
  • [Neuronal Calcium Sensor-1: A Zinc/Redox-Dependent Protein of Nervous System Signaling Pathways]. (PMID:38062964)
  • NCS-1 protein regulates TRPA1 channel through the PI3K pathway in breast cancer and neuronal cells. (PMID:38564162)

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
danio_rerioncs1bENSDARG00000054186
danio_rerioncs1aENSDARG00000055229
mus_musculusNcs1ENSMUSG00000062661
drosophila_melanogasterCG7646FBGN0036926
drosophila_melanogasterCG5890FBGN0039380
caenorhabditis_elegansncs-2WBGENE00003564
caenorhabditis_elegansWBGENE00015867

Paralogs (14): CLXN (ENSG00000034239), GUCA1A (ENSG00000048545), NCALD (ENSG00000104490), RCVRN (ENSG00000109047), GUCA1B (ENSG00000112599), KCNIP3 (ENSG00000115041), HPCAL1 (ENSG00000115756), HPCAL4 (ENSG00000116983), KCNIP2 (ENSG00000120049), HPCA (ENSG00000121905), GUCA1C (ENSG00000138472), VSNL1 (ENSG00000163032), KCNIP1 (ENSG00000182132), KCNIP4 (ENSG00000185774)

Protein

Protein identifiers

Neuronal calcium sensor 1P62166 (reviewed: P62166)

Alternative names: Frequenin homolog, Frequenin-like protein, Frequenin-like ubiquitous protein

All UniProt accessions (1): P62166

UniProt curated annotations — full annotation on UniProt →

Function. Neuronal calcium sensor, regulator of G protein-coupled receptor phosphorylation in a calcium dependent manner. Directly regulates GRK1 (RHOK), but not GRK2 to GRK5. Can substitute for calmodulin. Stimulates PI4KB kinase activity. Involved in long-term synaptic plasticity through its interaction with PICK1. May also play a role in neuron differentiation through inhibition of the activity of N-type voltage-gated calcium channel.

Subunit / interactions. Monomer. Interacts with KCND2. Interacts in a calcium-independent manner with PI4KB. This binding competes with CALN2/CABP7 binding to PI4KB. Interacts in a calcium-dependent manner with PICK1 (via AH domain). Interacts with ARF1, ARF3, ARF5 and ARF6. Interacts with IL1RAPL1. Interacts with RIC8A; interaction is favored in the absence of Ca(2+) and myristoylation of NCS1 is not required.

Subcellular location. Golgi apparatus. Postsynaptic density. Cytoplasm. Perinuclear region. Cell membrane. Membrane.

Miscellaneous. Binds 3 calcium ions via the second, third and fourth EF-hand.

Similarity. Belongs to the recoverin family.

Isoforms (2)

UniProt IDNamesCanonical?
P62166-11yes
P62166-22

RefSeq proteins (2): NP_001122298, NP_055101* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002048EF_hand_domDomain
IPR011992EF-hand-dom_pairHomologous_superfamily
IPR018247EF_Hand_1_Ca_BSBinding_site
IPR028846RecoverinFamily

Pfam: PF00036, PF13499

UniProt features (52 total): binding site 16, helix 14, strand 7, domain 4, mutagenesis site 4, sequence conflict 2, initiator methionine 1, chain 1, lipid moiety-binding region 1, splice variant 1, region of interest 1

Structure

Experimental structures (PDB)

14 structures.

PDBMethodResolution (Å)
9GUAX-RAY DIFFRACTION1.65
9GU8X-RAY DIFFRACTION1.67
8AHYX-RAY DIFFRACTION1.7
4GUKX-RAY DIFFRACTION1.75
6QI4X-RAY DIFFRACTION1.78
8ALMX-RAY DIFFRACTION1.85
8ALHX-RAY DIFFRACTION1.86
1G8IX-RAY DIFFRACTION1.9
9T0HX-RAY DIFFRACTION1.91
9GU6X-RAY DIFFRACTION1.93
9GUZX-RAY DIFFRACTION2.28
9GTOX-RAY DIFFRACTION2.3
5O9SX-RAY DIFFRACTION2.7
2LCPSOLUTION NMR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P62166-F188.260.65

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (16): 79; 81; 84; 109; 111; 113; 115; 120; 157; 159; 161; 163

Post-translational modifications (1): 2

Mutagenesis-validated functional residues (4):

PositionPhenotype
2no effect on interaction with ric8a.
81reduces calcium binding; when associated with a-117 or a-165. abolishes calcium binding; when associated with a-117 and
117reduces calcium binding; when associated with t-81. abolishes calcium binding; when associated with t-81 and a-165.
165reduces calcium binding; when associated with a-117. abolishes calcium binding; when associated with t-81 and a-117.

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 181 (showing top): TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, GOBP_NEUROGENESIS, GOBP_MONOATOMIC_CATION_TRANSPORT, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, BACH2_01, TGANTCA_AP1_C, TTGGAGA_MIR5155P_MIR519E, GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, GCM_MAPK10, GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT

GO Biological Process (3): regulation of signal transduction (GO:0009966), regulation of neuron projection development (GO:0010975), calcium ion transmembrane transport (GO:0070588)

GO Molecular Function (5): voltage-gated calcium channel activity (GO:0005245), calcium ion binding (GO:0005509), calcium sensitive guanylate cyclase activator activity (GO:0008048), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (10): cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), cytosol (GO:0005829), plasma membrane (GO:0005886), postsynaptic density (GO:0014069), axon (GO:0030424), dendrite (GO:0030425), perinuclear region of cytoplasm (GO:0048471), membrane (GO:0016020), synapse (GO:0045202)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
cytoplasm3
neuron projection2
signal transduction1
regulation of cell communication1
regulation of signaling1
regulation of response to stimulus1
neuron projection development1
regulation of plasma membrane bounded cell projection organization1
calcium ion transport1
monoatomic cation transmembrane transport1
calcium channel activity1
voltage-gated monoatomic cation channel activity1
metal ion binding1
guanylate cyclase activator activity1
binding1
cation binding1
intracellular anatomical structure1
endomembrane system1
intracellular membrane-bounded organelle1
membrane1
cell periphery1
asymmetric synapse1
postsynaptic specialization1
dendritic tree1
cell junction1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

127 interactions, top by confidence:

ABTypeScore
DTX2NCS1psi-mi:“MI:0915”(physical association)0.830
NCS1DTX2psi-mi:“MI:0915”(physical association)0.830
MGLLHPCAL1psi-mi:“MI:0914”(association)0.640
HSD17B3NCS1psi-mi:“MI:0915”(physical association)0.620
NCS1CEP89psi-mi:“MI:0915”(physical association)0.600
NBL1NCS1psi-mi:“MI:0915”(physical association)0.560
NCS1NBL1psi-mi:“MI:0915”(physical association)0.560
NCS1SFTPA2psi-mi:“MI:0915”(physical association)0.560
NCS1LY6G6Dpsi-mi:“MI:0915”(physical association)0.560
NCS1CREMpsi-mi:“MI:0915”(physical association)0.560
NCS1psi-mi:“MI:0915”(physical association)0.560
NCS1PRDM4psi-mi:“MI:0915”(physical association)0.560
NCS1CTAG1Apsi-mi:“MI:0915”(physical association)0.560
NCS1SIGLEC9psi-mi:“MI:0915”(physical association)0.560
NCS1SPRED2psi-mi:“MI:0915”(physical association)0.560
NCS1ZC3H10psi-mi:“MI:0915”(physical association)0.560

BioGRID (115): NCS1 (Two-hybrid), DTX2 (Two-hybrid), NCS1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), DTX2 (Two-hybrid), NCS1 (Proximity Label-MS), NCS1 (Two-hybrid), NCS1 (Affinity Capture-MS), IL1RAPL1 (Two-hybrid), BSPRY (Affinity Capture-MS), ABHD6 (Affinity Capture-MS), NMT2 (Affinity Capture-MS)

ESM2 similar proteins: A9JTH1, B3DLU1, B3VSB7, B5FZ84, P29104, P29105, P35332, P36608, P37235, P37236, P42324, P42325, P61601, P61602, P62166, P62167, P62168, P62748, P62749, P62758, P62759, P62760, P62761, P62762, P62763, P62764, P84074, P84075, P84076, Q06AT0, Q06AT1, Q09711, Q16982, Q28IM6, Q4PL64, Q4R4N4, Q4R5F7, Q5PQN0, Q5R632, Q5R6S5

Diamond homologs: A9JTH1, B3DLU1, B3VSB7, B5FZ84, O73761, O73762, O73763, O95843, P21457, P22728, P25296, P29104, P29105, P31227, P34057, P35243, P35332, P36608, P36609, P37235, P37236, P42322, P42324, P42325, P43080, P43081, P46065, P51177, P61601, P61602, P62166, P62167, P62168, P62748, P62749, P62758, P62759, P62760, P62761, P62762

SIGNOR signaling

5 interactions.

AEffectBMechanism
NCS1“down-regulates activity”DRD2binding
NCS1“down-regulates activity”GRK2binding
IL1RAPL1“up-regulates activity”NCS1binding
NCS1“up-regulates activity”PI4KB
IL1RAPL2“up-regulates activity”NCS1binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 94 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
TNFR1-induced NF-kappa-B signaling pathway528.0×6e-04
MAPK family signaling cascades58.6×9e-03

GO biological processes:

GO termPartnersFoldFDR
canonical NF-kappaB signal transduction522.3×2e-03
negative regulation of canonical NF-kappaB signal transduction612.6×3e-03
positive regulation of canonical NF-kappaB signal transduction87.1×3e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

23 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance9
Likely benign1
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

1933 predictions. Top by Δscore:

VariantEffectΔscore
9:130172717:G:GTdonor_gain1.0000
9:130172723:CTACT:Cdonor_gain1.0000
9:130172724:TACT:Tdonor_gain1.0000
9:130172725:ACT:Adonor_gain1.0000
9:130172725:ACTGT:Adonor_loss1.0000
9:130172726:CT:Cdonor_gain1.0000
9:130172726:CTG:Cdonor_loss1.0000
9:130172727:TG:Tdonor_loss1.0000
9:130172728:G:Cdonor_loss1.0000
9:130172728:G:GGdonor_gain1.0000
9:130172729:T:Gdonor_loss1.0000
9:130200980:GTG:Gdonor_gain1.0000
9:130217820:T:TAacceptor_gain1.0000
9:130217823:T:Aacceptor_gain1.0000
9:130217830:A:Cacceptor_loss1.0000
9:130217971:G:GCdonor_loss1.0000
9:130219719:TGTCA:Tacceptor_loss1.0000
9:130219720:GTCA:Gacceptor_loss1.0000
9:130219721:TCA:Tacceptor_loss1.0000
9:130219722:CAGG:Cacceptor_loss1.0000
9:130219723:A:AGacceptor_gain1.0000
9:130219723:A:ATacceptor_loss1.0000
9:130219723:AG:Aacceptor_gain1.0000
9:130219723:AGGAC:Aacceptor_gain1.0000
9:130219724:G:GAacceptor_gain1.0000
9:130219724:GG:Gacceptor_gain1.0000
9:130219724:GGAC:Gacceptor_gain1.0000
9:130219724:GGACG:Gacceptor_gain1.0000
9:130219797:C:Gdonor_gain1.0000
9:130219799:ACGGT:Adonor_gain1.0000

AlphaMissense

1267 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
9:130217842:T:CF34L1.000
9:130217843:T:CF34S1.000
9:130217844:C:AF34L1.000
9:130217844:C:GF34L1.000
9:130219740:T:CF82L1.000
9:130219742:C:AF82L1.000
9:130219742:C:GF82L1.000
9:130219780:G:AG95E1.000
9:130219798:T:CL101P1.000
9:130222655:T:CF105L1.000
9:130222657:C:AF105L1.000
9:130222657:C:GF105L1.000
9:130222689:T:AI116N1.000
9:130222721:G:CA127P1.000
9:130226419:T:CF169L1.000
9:130226420:T:CF169S1.000
9:130226421:C:AF169L1.000
9:130226421:C:GF169L1.000
9:130172710:T:CL16P0.999
9:130200973:T:AV27D0.999
9:130217843:T:GF34C0.999
9:130217870:T:CL43P0.999
9:130217884:T:CF48L0.999
9:130217885:T:CF48S0.999
9:130217886:C:AF48L0.999
9:130217886:C:GF48L0.999
9:130217905:T:CF55L0.999
9:130217907:C:AF55L0.999
9:130217907:C:GF55L0.999
9:130217908:T:CF56L0.999

dbSNP variants (sampled 300 via entrez): RS1000091266 (9:130223771 A>C,G,T), RS1000192258 (9:130228164 A>G), RS1000327841 (9:130233938 G>A,C), RS1000352424 (9:130195791 G>A,T), RS1000497876 (9:130174287 G>A), RS1000510663 (9:130212185 G>A), RS1000557203 (9:130180386 C>A), RS1000563205 (9:130210757 A>G,T), RS1000634181 (9:130222240 C>A,T), RS1000715554 (9:130185046 A>G), RS1000741134 (9:130215863 T>C), RS1000942749 (9:130199957 G>C), RS1001017349 (9:130205332 T>A,G), RS1001116912 (9:130211256 C>G), RS1001298246 (9:130205972 T>C)

Disease associations

OMIM: gene MIM:603315 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST001915_24Alzheimer’s disease (cognitive decline)7.000000e-07
GCST007231_10Tuberculosis2.000000e-06

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (2): CHEMBL4295788 (SINGLE PROTEIN), CHEMBL4296100 (PROTEIN COMPLEX)

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

1 potent at pChembl≥5 of 2 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
5.90Kd1250nMCHEMBL3235533

PubChem BioAssay actives

1 with measured affinity, of 6 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
N-(1,3-benzothiazol-2-yl)-3,3-diphenylpropanamide1350731: Binding affinity to human NCS1 expressed in Escherichia coli BL21 Star (DE3) by fluorescence emission assaykd1.2500uM

CTD chemical–gene interactions

38 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases expression2
Benzo(a)pyreneaffects methylation, increases expression2
Estradiolaffects cotreatment, increases expression2
Valproic Acidincreases methylation, affects expression, decreases expression2
Cadmium Chlorideincreases expression2
propylparabenincreases expression1
bisphenol Aincreases expression1
glycidyl methacrylateincreases expression1
lead acetateincreases expression1
methylparabenincreases expression1
benzo(e)pyrenedecreases methylation1
cupric chlorideincreases expression1
abrinedecreases expression1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidinedecreases expression, increases response to substance1
(+)-JQ1 compounddecreases expression1
Temozolomidedecreases expression1
Decitabineincreases expression1
Sunitinibincreases expression1
Vorinostatdecreases expression1
Acetaminophenincreases expression1
Air Pollutantsincreases expression, increases abundance1
Benzoatesdecreases expression1
Cisplatinincreases expression1
Dichlorodiphenyl Dichloroethyleneincreases expression1
Doxorubicindecreases expression1
Ivermectindecreases expression1
Leadaffects expression1
Methapyrilenedecreases methylation1
Smokedecreases expression1
Tretinoindecreases expression1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4145365BindingBinding affinity to human NCS1 expressed in Escherichia coli BL21 Star (DE3) by fluorescence emission assayDeciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function Regulators. — J Med Chem

Cellosaurus cell lines

1 cell lines: 1 induced pluripotent stem cell

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D6KMHMGUi001-A-22Induced pluripotent stem cellFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): tuberculosis